WALTHAM, Mass., Oct. 17 /PRNewswire-FirstCall/ --
AltaRex Corp. (TSE: AXO, OTC: ALXFF.PK) announced today that it will present a
corporate update at the TechVest Healthcare Conference on Tuesday, October 22,
2002 at 3:55 p.m. EST and at the Mass Opportunities Investor Conference on
Monday, October 28, 2002 at 10:30 a.m. EST.
Presenter: Richard Bagley, President & CEO
About AltaRex:
-- Proprietary technology platform using foreign antibodies to induce
immunity
-- OvaRex(R) MAb phase III product to treat late stage ovarian cancer;
integrating partners' clinical and manufacturing programs (US, EU); in
discussions for remaining EU territory
-- Approach applicable to multiple diseases (cancer, chronic infectious,
autoimmune and allergy); opportunity for additional collaborations
-- Downsized, platform and product company
Webcasts:
TechVest Health Conference
Tuesday, October 22, 2002 at 3:55 p.m. EST
Live Audio Webcast with 30 day archive
AltaRex Corp. URL via Techvest:
http://www.visualwebcaster.com/event.asp?id=8348
Mass Opportunities Investor Conference
Monday, October 28, 2002 at 10:30 a.m. EST
Live Audio Webcast with 90 day archive
AltaRex Corp. URL via MassOps:
http://www.visualwebcaster.com/event.asp?id=8944
For additional information about AltaRex, visit the Company website at
http://www.altarex.com.
THE TORONTO STOCK EXCHANGE HAS NOT APPROVED OR DISAPPROVED OF THE
INFORMATION CONTAINED HEREIN
Contact:
Trudy Chimko
Corporate Communications
(781) 672-0138
investor@altarex.com
SOURCE AltaRex Corp.
back to top
